Immunomodulatory compounds for the restoration of vitamin D sensitivity in vitamin D resistant tumor cells
US8841325B2 · kind B2 · utility
2Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 2010 |
| Grant date | Sep 23, 2014 |
| Priority date | — |
| Expiry date | Apr 11, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5011
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods of restoring vitamin D sensitivity in tumor cells that are vitamin D resistant. Also provided are methods of treating, preventing or managing cancer using an immunomodulatory compound in combination with a vitamin D agent. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods provided herein are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.